Sunflower plans to acquire equity in Xipu Materials, a high-end semiconductor materials company.

Category:

Industry News

Author:

Source:

Release time:

2025-09-22

Visits:

On September 21, Sunflower (300111.SZ) announced that the company plans to acquire 100% equity of Zhangzhou Xipu Materials Technology Co., Ltd. and 40% equity of Zhejiang Beide Pharmaceutical Co., Ltd. through share issuance and cash payment, while also raising supporting funds. The company's shares will resume trading tomorrow.

According to the announcement, Xipu Materials primarily engages in the research and development, manufacturing, and sales of high-end semiconductor materials. Its key products include semiconductor-grade high-purity electronic specialty gases, silicon-based precursors, metal-based precursors, and more—materials widely used in critical process steps of semiconductor manufacturing, such as diffusion, etching, and thin-film deposition. Meanwhile, Bede Pharmaceutical, as a controlling subsidiary of Sunflower, focuses on the research, development, manufacturing, and sales of drugs targeting areas like anti-infectives, cardiovascular treatments, and digestive system therapies.

This acquisition aims to further expand Sunflower's business areas and enhance the company's competitiveness in the high-end semiconductor materials market. The addition of Xipu Materials will bring advanced technology and a robust product portfolio to Sunflower, supporting the company's strategic positioning within the semiconductor industry chain. Meanwhile, increasing the stake in Bede Pharmaceutical will further strengthen the company's presence in the pharmaceutical sector.

The background behind this acquisition lies in Sunflower's pursuit of diversified growth and the enhancement of its core competitiveness. With the rapid advancement of the semiconductor industry, demand for high-end semiconductor materials remains robust. The integration of Xipu Materials will provide Sunflower with new opportunities for growth.

This acquisition holds significant importance for both the company and its investors. On one hand, the acquisition of Xipu Materials will substantially boost Sunflower's market share and technological strength in the semiconductor materials sector, paving the way for the company's long-term growth. On the other hand, increasing the stake in Bede Pharmaceutical will strengthen the company's overall competitiveness in the pharmaceutical industry, enhancing its profitability.

Pre

NVIDIA to Invest $100 Billion in OpenAI

NVIDIA invests $5 billion in Intel to strengthen collaboration on chip development.

NVIDIA to Invest $100 Billion in OpenAI

NVIDIA invests $5 billion in Intel to strengthen collaboration on chip development.

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

Business License